IntegenX this week launched its RapidHit 200 Human DNA Identification System in Europe.
The RapidHit 200 is a fully automated and closed sample-to-profile DNA analysis system that integrates cell lysis, DNA extraction, PCR amplification, capillary electrophoresis-based separation, and laser-induced fluorescence detection.
The system can produce DNA profiles from buccal swabs or other human samples in less than 90 minutes, and will enable DNA analysis at the point of collection, such as an arrest or detention, according to the company.
IntegenX, based in Pleasanton, Calif., plans to market the system for use in field-based applications in forensics, defense, homeland security, and other markets.
The company launched its system this week at the European Academy of Forensic Science conference in The Hague, The Netherlands. It said that it plans to launch the platform in the US market at the International Association of Chiefs of Police Conference and Law Enforcement Education and Technology Symposium, to be held Sept. 20-Oct. 3 in San Diego.
Earlier this year IntegenX acquired SV Corp from GE Healthcare Biosciences for its IP covering CE, separation, and sample prep (PCR Insider, 5/2/2012). The company also has a reagent supply agreement with Promega for that company's nucleic acid purification and short tandem repeat amplification reagents (PCR Insider, 8/4/2011).